Evaluation of Non-typable Haemophilus Influenzae and Pneumococcal Protein Vaccine Formulations in Young Adults

NCT00814489 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Streptococcus Pneumoniae
Haemophilus Influenzae

Interventions

BIOLOGICAL: GSK2231395A
BIOLOGICAL: Engerix-B

Sponsor

GlaxoSmithKline